메뉴 건너뛰기




Volumn 26, Issue 3, 1998, Pages 329-347

Pharmacokinetic and pharmacodynamic evaluation for tissue-selective inhibition of cholesterol synthesis by pravastatin

Author keywords

Cholesterol synthesis; HMG CoA reductase inhibitors; Pharmacodynamics; Pharmacokinetics; Pravastatin; Tissue selectivity

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

EID: 0032456123     PISSN: 0090466X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (17)

References (25)
  • 1
    • 0023521261 scopus 로고
    • 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of hypercholesterolemia
    • J. M. Hoeg and H. B. Brewer, Jr. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of hypercholesterolemia. J. Am. Med. Assoc. 258:3532-3536 (1987).
    • (1987) J. Am. Med. Assoc. , vol.258 , pp. 3532-3536
    • Hoeg, J.M.1    Brewer H.B., Jr.2
  • 2
    • 0028096810 scopus 로고
    • A review of clinical trials comparing HMG-CoA reductase inhibitors
    • D. R. Illingworth and J. A. Tobert. A review of clinical trials comparing HMG-CoA reductase inhibitors. Clin. Ther. 16:366-385 (1994).
    • (1994) Clin. Ther. , vol.16 , pp. 366-385
    • Illingworth, D.R.1    Tobert, J.A.2
  • 3
    • 0025944198 scopus 로고
    • Relative lipophilicities, solubilities, and structure-pharmacological consideration of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin
    • A. T. M. Serajuddin, S. A. Ranadive, and E. M. Mahoney. Relative lipophilicities, solubilities, and structure-pharmacological consideration of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin. J. Pharm. Sci. 80:830-834 (1991).
    • (1991) J. Pharm. Sci. , vol.80 , pp. 830-834
    • Serajuddin, A.T.M.1    Ranadive, S.A.2    Mahoney, E.M.3
  • 5
    • 0027375980 scopus 로고
    • Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone
    • K. Ziegler and S. Hummelsiep. Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone. Biochim. Biophys. Acta 1153:23-33 (1993).
    • (1993) Biochim. Biophys. Acta , vol.1153 , pp. 23-33
    • Ziegler, K.1    Hummelsiep, S.2
  • 7
    • 0022485201 scopus 로고
    • CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
    • Y. Tsujita, M. Kuroda, Y. Shimada, K. Tanizawa, M. Arai, I. Kaneko, M. Tanaka, H. Masuda, C. Tarumi, Y. Watanabe, and S. Fuji. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim. Biophys. Acta 877:50-60 (1986).
    • (1986) Biochim. Biophys. Acta , vol.877 , pp. 50-60
    • Tsujita, Y.1    Kuroda, M.2    Shimada, Y.3    Tanizawa, K.4    Arai, M.5    Kaneko, I.6    Tanaka, M.7    Masuda, H.8    Tarumi, C.9    Watanabe, Y.10    Fuji, S.11
  • 8
    • 0025286202 scopus 로고
    • Tissue-selective inhibition of cholesterol synthesis in vitro by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
    • T. Koga, Y. Shimada, M. Kuroda, Y. Tsujita, K. Hasegawa, and M. Yamazaki. Tissue-selective inhibition of cholesterol synthesis in vitro by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim. Biophys. Acta 1045:115-120 (1990).
    • (1990) Biochim. Biophys. Acta , vol.1045 , pp. 115-120
    • Koga, T.1    Shimada, Y.2    Kuroda, M.3    Tsujita, Y.4    Hasegawa, K.5    Yamazaki, M.6
  • 10
    • 0028814860 scopus 로고
    • Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types
    • A. K. van Vliet, G. C. F. van Thiel, R. H. Huisman, H. Moshage, S. H. Yap, and L. H. Cohen. Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on sterol synthesis in various human cell types. Biochim. Biophys. Acta 1254:105-111 (1995).
    • (1995) Biochim. Biophys. Acta , vol.1254 , pp. 105-111
    • Van Vliet, A.K.1    Van Thiel, G.C.F.2    Huisman, R.H.3    Moshage, H.4    Yap, S.H.5    Cohen, L.H.6
  • 11
    • 0024330631 scopus 로고
    • Quantitative evaluation of targeted drug delivery systems
    • P. K. Gupta and C. T. Hung. Quantitative evaluation of targeted drug delivery systems. Int. J. Pharm. 56:217-226 (1989).
    • (1989) Int. J. Pharm. , vol.56 , pp. 217-226
    • Gupta, P.K.1    Hung, C.T.2
  • 12
    • 0023104859 scopus 로고
    • Targeted drug delivery: Some pharmacokinetic considerations
    • G. Levy. Targeted drug delivery: Some pharmacokinetic considerations. Pharm. Res. 4:3-4 (1987).
    • (1987) Pharm. Res. , vol.4 , pp. 3-4
    • Levy, G.1
  • 13
    • 0024373204 scopus 로고
    • Pharmacokinetic and pharmacodynamic aspects of site-specific drug delivery
    • A. Boddy and L. Aarons. Pharmacokinetic and pharmacodynamic aspects of site-specific drug delivery. Adv. Drug Deliv. Rev. 3:155-163 (1989).
    • (1989) Adv. Drug Deliv. Rev. , vol.3 , pp. 155-163
    • Boddy, A.1    Aarons, L.2
  • 15
    • 0001449559 scopus 로고
    • The routine fitting of kinetic data to models: A mathematical formalism for digital computers
    • M. Berman, E. Shahn, and M. F. Weiss. The routine fitting of kinetic data to models: A mathematical formalism for digital computers. Biophys. J. 2:275-287 (1962).
    • (1962) Biophys. J. , vol.2 , pp. 275-287
    • Berman, M.1    Shahn, E.2    Weiss, M.F.3
  • 16
    • 0017055252 scopus 로고
    • ML-236A, ML-236B and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrium
    • A. Endo, M. Kuroda, and Y. Tsujita. ML-236A, ML-236B and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrium. J. Antibiot. 29:1346-1348 (1977).
    • (1977) J. Antibiot. , vol.29 , pp. 1346-1348
    • Endo, A.1    Kuroda, M.2    Tsujita, Y.3
  • 17
    • 0017754661 scopus 로고
    • Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
    • A. Endo, Y. Tsujita, M. Kuroda, and K. Tanzawa. Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur. J. Biochem. 77:31-36 (1977).
    • (1977) Eur. J. Biochem. , vol.77 , pp. 31-36
    • Endo, A.1    Tsujita, Y.2    Kuroda, M.3    Tanzawa, K.4
  • 18
    • 0026567257 scopus 로고
    • Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors
    • T. M. A. Bocan, E. Ferguson, W. McNally, P. D. Uhlendorf, S. B. Muller, P. Dehart, D. R. Sliskovic, B. D. Roth, B. R. Krause, and R. S. Newton. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors. Biochim. Biophys. Acta 1123:133-144 (1992).
    • (1992) Biochim. Biophys. Acta , vol.1123 , pp. 133-144
    • Bocan, T.M.A.1    Ferguson, E.2    McNally, W.3    Uhlendorf, P.D.4    Muller, S.B.5    Dehart, P.6    Sliskovic, D.R.7    Roth, B.D.8    Krause, B.R.9    Newton, R.S.10
  • 20
    • 0025355830 scopus 로고
    • Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects
    • S. M. Singhvi, H. Y. Pan, R. A. Morrison, and D. A. Willard. Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects. Br. J. Clin. Pharmacol. 29:239-243 (1990).
    • (1990) Br. J. Clin. Pharmacol. , vol.29 , pp. 239-243
    • Singhvi, S.M.1    Pan, H.Y.2    Morrison, R.A.3    Willard, D.A.4
  • 22
    • 0020279521 scopus 로고
    • Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data
    • J. H. Lin, Y. Sugiyama, S. Awazu, and M. Hanano. Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data. J. Pharmacokin. Biopharm. 10:649-661 (1982).
    • (1982) J. Pharmacokin. Biopharm. , vol.10 , pp. 649-661
    • Lin, J.H.1    Sugiyama, Y.2    Awazu, S.3    Hanano, M.4
  • 23
    • 0028029150 scopus 로고
    • Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism
    • A. Tsuji, H. Takanaga, I. Tamai, and T. Terasaki, Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism. Pharm. Res. 11:30-37 (1994).
    • (1994) Pharm. Res. , vol.11 , pp. 30-37
    • Tsuji, A.1    Takanaga, H.2    Tamai, I.3    Terasaki, T.4
  • 24
    • 0345482570 scopus 로고
    • Pharmacokinetics of HMG-CoA reductase inhibitors
    • K. Sasahara. Pharmacokinetics of HMG-CoA reductase inhibitors. Prog. Med. 11:2413-2427 (1991).
    • (1991) Prog. Med. , vol.11 , pp. 2413-2427
    • Sasahara, K.1
  • 25
    • 0021961770 scopus 로고
    • 3-Hydroxy-3-methylglutaryl-coenzyme A reductase is present in peroxisome in normal rat liver cells
    • G. A. Keller, M. C. Barton, D. J. Shapiro, and S. J. Singer. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase is present in peroxisome in normal rat liver cells. Proc. Natl. Acad. Sci. U.S. 82:770-774 (1985).
    • (1985) Proc. Natl. Acad. Sci. U.s. , vol.82 , pp. 770-774
    • Keller, G.A.1    Barton, M.C.2    Shapiro, D.J.3    Singer, S.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.